Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
flu
Podcast
'The Top Line': A checklist for immuno-oncology combo phase 3 trials
This week on "The Top Line," we discuss a checklist that the Society for Immunotherapy of Cancer released and the top headlines from this week.
Teresa Carey
Feb 24, 2023 6:00am
COPD Foundation links arms with Ena on antiviral nasal spray
Feb 28, 2022 11:29am
GlaxoSmithKline offers grants to highlight sick pay inequities
Nov 23, 2021 12:55pm
Roche's Genentech gets animated in new DTC for one-dose Xofluza
Feb 2, 2021 9:15am
RB, Mucinex team with Kinsa to track cold and flu season
Sep 29, 2020 10:00am
Novavax, Fujifilm lock up supply for phase 3 COVID-19 shot trial
Jul 24, 2020 9:05am
